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Abstract 
Background: Difficulties to disentangle the protective versus exposure role of anti-malarial antibodies hamper the 
identification of clinically-relevant immune targets. Here, factors affecting maternal IgG and IgMs against Plasmodium 
falciparum antigens, as well as their relationship with parasite infection and clinical outcomes, were assessed in moth-
ers and their children. Antibody responses among 207 Mozambican pregnant women at delivery against  MSP119, 
EBA175, AMA1, DBLα and parasite lysate (3D7, R29 and E8B parasite lines), as well as the surface of infected erythro-
cytes, were assessed by enzyme-linked immunosorbent assay and flow cytometry. The relationship between antibody 
levels, maternal infection and clinical outcomes was assessed by multivariate regression analysis.
Results: Placental infection was associated with an increase in maternal levels of IgGs and IgMs against a broad 
range of parasite antigens. The multivariate analysis including IgGs and IgMs showed that the newborn weight 
increased with increasing IgG levels against a parasite lysate, whereas the opposite association was found with IgMs. 
IgGs are markers of protection against poor pregnancy outcomes and IgMs of parasite exposure.
Conclusions: Adjusting the analysis for the simultaneous effect of IgMs and IgGs can contribute to account for het-
erogeneous exposure to P. falciparum when assessing immune responses effective against malaria in pregnancy.
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Background
Plasmodium falciparum infection during pregnancy, 
characterized by the accumulation of parasites in the 
intervillous spaces of the placenta, is a major disease that 
affects birth outcome in sub-Saharan Africa [1], causing 
up to 100,000 infant deaths annually [2]. In contrast to 
non-pregnant adults, pregnant women are at increased 
risk of malaria infection independently of previous acqui-
sition of immunity [3]. In conditions of high malaria 
transmission, this susceptibility decreases with subse-
quent pregnancies [3], suggesting a parity-dependent 
acquisition of protective immunity. Understanding the 
targets, quality and quantity of the immune responses 
that pregnant women mount upon infection and their 
role, in protection against infection and its adverse 
effects in pregnancy (i.e., low newborn weight, stillbirth 
and maternal anaemia) is of critical importance to design 
effective vaccines specific for pregnant women [4].
Immunoglobulin G (IgG) antibodies against placen-
tal infected erythrocytes (IE) and VAR2CSA [5], the 
major variant surface antigen on the surface of P. falci-
parum infected erythrocytes that binds chondroitin sul-
fate A (CSA) [6] to enable sequestration in the placenta 
[7], increase with parity [8]. These antibodies have been 
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associated with reduced risk of placental infection [5, 9–
11], low birth weight [12–15] and maternal anaemia [14, 
16]. However, several other studies have failed to show 
such a protective association [11, 17–22], but instead 
suggested that antibodies at delivery reflect exposure to 
P. falciparum in pregnancy [8, 9, 21–28].
Recent studies show how the power to identify immune 
correlates of protection in children [29–31] and pregnant 
women [28] under heterogeneous intensities of malaria 
transmission can be reduced by inclusion of individu-
als with different degrees of exposure [29]. Heterogene-
ity in exposure to P. falciparum [9, 22, 27] can be taken 
into account by including in the analysis only women 
with proven parasite exposure before delivery (i.e., hav-
ing had a malaria episode during pregnancy) [28]. How-
ever, this requires the morbidity surveillance at antenatal 
care units of rural hospitals in African countries that is 
not always available. There is a need to develop better 
methods to adjust for heterogeneity in parasite exposure 
when assessing immune responses that contribute to 
protection against malaria infection in pregnancy [30]. 
The aim of this study was to assess an alternative way 
of accounting for the effect of heterogeneous exposure 
to P. falciparum in the absence of information before 
delivery. Specifically, the objective was to assess the rela-
tionship of IgG and IgM against P. falciparum antigens 
in Mozambican pregnant women at delivery with para-
site infection and adverse clinical impacts in the moth-
ers and newborns. Pregnancy-specific antigens (infected 
erythrocytes selected from binding to CSA and placental 
isolates), general (non-pregnancy specific) antigens (mer-
ozoite antigens, non-CSA binder P. falciparum lines and 
isolates) and a parasite lysate (to assess responses against 
all whole-parasite antigens) were included. IgG but also 
IgM were assessed given their contribution for protection 
against infection [32], both in maternal and cord blood 
to assess the effect of placentally-transferred antibodies 
in reducing the risk of clinical malaria in children dur-
ing their 1st year of life. The study was conducted in a 
mother and child cohort living in a malaria endemic area 
of Mozambique, in the context of a randomized, double-
blind, placebo-controlled trial [“Age of exposure and 
immunity to malaria in infants” (AgeMal)] [33].
Methods
Study area
The study was conducted at the Centro de Investigação 
em Saúde de Manhiça (CISM), located in the Manhiça 
District, Maputo Province, southern Mozambique. The 
area has been described in detail elsewhere [34]. Trans-
mission of P. falciparum is perennial and of moderate 
intensity with a warm rainy season from November to 
April, and a cool dry season during the rest of the year.
Study design and samples collection
HIV-negative pregnant women resident in the Manhiça 
study area were recruited during the third trimester of 
pregnancy at the antenatal clinic of the Maragra Health 
Post (MHP), in the south of the study area, from Septem-
ber 2005 to March 2007 [33]. After delivery, neonates 
were evaluated for eligibility. Exclusion criteria included 
birth weight < 2  kg, twins, congenital malformations, 
birth asphyxia or apparent health problems. Three-hun-
dred and 49 eligible newborns were enrolled in the trial.
At delivery, maternal peripheral and cord blood sam-
ples collected into EDTA vacutainers were centrifuged 
and plasma stored at − 20  °C for future antibody deter-
minations. Thin and thick smears of peripheral and cord 
blood were Giemsa-stained and examined for malarial 
parasites according to quality-control procedures [33]. 
Haemoglobin (Hb) levels were determined on full blood 
counts performed using a Sysmex KX-21N cell counter 
(Sysmex Corporation, Kobe, Japan). Peripheral and cord 
blood was also collected onto filter papers for P. falcipa-
rum detection by real-time quantitative PCR (RTqPCR) 
in duplicates [35]. Tissue samples obtained from the 
maternal side of the placenta were processed for histolog-
ical examination and classified as negative, acute, chronic 
or past infections [36]. When the delivery occurred out-
side the maternity post, only the mother blood sample 
was collected.
Children were followed up until age 24  months, 
with weekly active case detection from birth to age 
10.5  months, and monthly home visits from 10.5 to 
24 months of age. Children were examined and their par-
asitaemia and haematocrit determined if they presented 
fever (axillary temperature ≥ 37.5  °C) or their guardians 
referred history of fever in the preceding 24 h. Addition-
ally, passive case detection was carried out at the MHP 
and Manhiça District Hospital (MDH) through the mor-
bidity surveillance system to monitor attendances to the 
outpatient clinics and admissions to hospital.
Informed consent was sought to enroll pregnant 
women and their newborn children in the study upon 
birth. The protocol was approved by the National 
Mozambican Ethics Review Committee and the Hospital 
Clínic of Barcelona Ethics Review Committee. The trial 
was conducted according to the ICH Good Clinical Prac-
tice guidelines and reviewed by a Local Safety Monitor 
and a Data and Safety Monitoring Board. The trial was 
registered in ClinicalTrials.gov (clinical trials identifier 
NCT00231452).
Measurement of antibodies against recombinant antigens
Recombinant merozoite surface protein 1 (MSP1; C-ter-
minal 19-kD fragment, 3D7 strain) [37], erythrocyte-
binding antigen 175 (EBA175; region F2, Camp strain) 
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[38], apical membrane antigen-1 (AMA1; full ectodo-
main, 3D7 strain) [39], Duffy binding-like alpha domain 
(DBLα; CR1-binding minimal domain of the erythro-
cyte membrane protein 1 expressed by P. falciparum 
R29-rosetting + line) [40] were produced in Escherichia 
coli, refolded if the protein was insoluble and purified 
(> 95%) following previously described methods [38]. 
Enzyme-linked immunosorbent assay (ELISA) plates 
were coated with 200 ng of recombinant antigen per well 
and sequentially incubated with 100 μL of peripheral and 
cord plasma (1:500) in duplicate, and secondary peroxi-
dase-conjugated goat anti-human IgG (1:30,000) or IgM 
(1:2000) [21, 41]. Reactions were developed as described 
previously [21] and OD values determined at 492 nm. Fif-
teen plasma samples from peripheral and cord blood of 
Spanish pregnant women who had never been exposed 
to malaria were used as negative controls. The ELISA 
reactivity of each sample was expressed as the percentage 
of the value obtained with the positive pool (11 plasma 
samples from hyperimmune Mozambican adults) in each 
experiment.
Measurement of antibodies against whole parasite extract
Whole-parasite lysate was prepared by three freezing/
thawing cycles of asynchronous in vitro cultures of 3D7, 
R29 and E8B laboratory strains at a 5% level of parasitae-
mia and 1% haematocrit, as previously described [21]. 
Non-infected erythrocyte (NIE) lysate, prepared using 
the same procedure as whole-parasite lysate, was used as 
a control of unspecific recognition for each plasma sam-
ple. ELISA plates were coated with 50  µL of lysate per 
well. Wells were blocked with 300  µL of 5% skim milk 
at 4 °C for 8 h. One hundred microliters of plasma sam-
ple were tested in duplicate for IgG and IgM (dilution, 1: 
1600). Incubation of antibodies and development of the 
reaction were performed as described above. Malaria-
specific antibody recognition was evaluated by subtract-
ing the mean OD value of NIEs from the mean OD value 
of IEs. The pool of positive plasmas was used to nor-
malize the data from different ELISAs and results were 
expressed as arbitrary units. Cutoff values for positivity 
were calculated as the arithmetic mean plus 3 standard 
deviations of 14 plasma samples from Spanish pregnant 
women who had never been exposed to malaria.
Measurement of antibodies against the surface 
of Plasmodium falciparum‑infected erythrocytes
Cryopreserved O+ erythrocytes infected by two placen-
tal isolates previously confirmed to express VAR2CSA 
[25]  (IEPlac1 and  IEPlac2), five pediatric isolates  (IECh1–
Ch4 and  IESEV) from Manhiça [25] and a CSA-binding 
parasite line adapted to culture (CS2) were thawed and 
matured to trophozoite stage without in vitro expansion. 
Erythrocytes at 1% haematocrit were sequentially incu-
bated with test plasma (1:20), rabbit anti-human IgG 
(1:200) and AlexaFluor donkey anti-rabbit IgG (1:1000) 
plus 10  μg/mL of ethidium bromide. Reactivity against 
the surface of IEs was expressed as the difference between 
the geometric mean fluorescence intensity (MFI) of 1000 
IEs and the MFI of NIE obtained in a FACSCalibur flow 
cytometer (BD, San Jose, USA). A pool of plasma sam-
ples from 10 Mozambican pregnant women was used to 
normalize the data from different assays [21] and results 
were expressed as arbitrary units.
Definitions and statistical methods
Pregnant women were classified into first-time mothers 
(primigravida, PG), those with one previous pregnancy 
(secundigravia, SG) and those with more than two pre-
vious pregnancies (multigravida, MG). Age was catego-
rized as ≤ 20, 21–24 and ≥ 25  years. Maternal anaemia 
was considered if the haemoglobin level was < 11  g/dL 
and low birth weight if the newborn weight was < 2500 g. 
Distance to the river was calculated with Hawth’s tools 
in ArcGIS software (ESRI) as the mean distance of each 
neighbourhood centroid to the Incomati river, and neigh-
bourhoods were classified as those adjacent to the river 
(≤ 2.5 km) or those at a higher distance (> 2.5 km) [28]. 
Season during pregnancy was defined as dry if the period 
of pregnancy included the cool dry season (May to Octo-
ber), and rainy if it included four or more rainy months 
(November to April). Maternal malaria in peripheral 
blood was defined as the presence of parasites detected in 
peripheral blood by optical microscopy and/or RTqPCR. 
Placental malaria was defined by the presence of malaria 
parasites and/or pigment as detected by histology. Pla-
cental inflammation was defined as the presence of > 5 
mononuclear and/or polymorphonuclear leukocytes in 
the intervillous spaces, assessed in 10 high power fields 
at 400× [42].
Continuous variables were compared by ANOVA, 
and categorical variables by Chi squared test or Fisher’s 
exact test. To identify factors that affect maternal IgG 
and IgM against P. falciparum antigens, the association 
of antibody levels (log transformed ODs or MFIs) with 
P. falciparum infection (maternal, placental, cord), pla-
cental inflammation, parity, neighbourhood, season and 
use of insecticide treated nets (ITN) or indoor residual 
spraying (IRS) were assessed by linear regression mod-
els. For those variables with negative values (IgGs against 
infected erythrocytes), prior to applying the log trans-
form a constant value was added to the data to obtain a 
minimum value less than 1. All the analyses were done 
univariate and multivariate, adjusting for all the other 
independent variables. To determine the relationship 
of antibody responses with clinical outcomes, parasite 
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infection and clinical outcomes in mothers and their 
children, the association of antibody levels (independ-
ent variable) with maternal haematocrit and weight of 
the newborn (dependent variable) was assessed, includ-
ing a multivariate analysis with all the antibody responses 
as independent variables. Negative binomial regression 
models were used to evaluate the effect of doubling the 
levels of antibodies on the incidence of multiple malaria 
episodes in children up to 12 months of age [33]. Analy-
ses were adjusted for maternal age, parity, use of IRS, use 
of ITN, season, neighbourhood, child anti-malarial inter-
vention [33] and P. falciparum infection in the mother. To 
assess if parity modified the associations, an interaction 
term was included in the regression models, and ratios 
and 95% confidence intervals (95% CI) for each antibody 
responses were estimated after stratifying the regression 
models. Analyses were performed using Stata 11 (Col-
lege Station, TX, USA) and significance was defined at 
p < 0.05.
Results
Factors related to P. falciparum infection in pregnancy
The analysis of antibody responses included 207 women 
(Table 1), 42 (20%) with peripheral infection at delivery, 
47 (23%) with placental infection (acute infection in 5 
[11%], chronic infection in 1 [2%] and past infection in 
41 [87%]), and 8 (4%) with cord blood infection. Placental 
inflammation in 10 (5%) of the women was more fre-
quent in women with peripheral infection than unin-
fected women. Placental infection decreased with parity 
(Table  1) and age of the women (35% [25 out of 71] if 
≤ 20 years, 16% [9 out of 58] if 21–24 years and 17% [13 
out of 78] if ≥ 25 years; p = 0.011), and was more frequent 
among women living in a house that had not received 
IRS (29% [32 out of 109]) than in those living in a house 
that received IRS (15% [15 out of 98]; p = 0.020). Cord 
blood infection was more frequent among women with 
placental inflammation (20% [2 out of 10]) than in those 
without inflammation (3% [6 out of 197]; p = 0.05). The 
use of ITN was higher among MG women (17% [18 out 
of 103]) than SG (4% [2 out of 47]) or PG women (5% [3 
out of 57]; p = 0.020). LBW was more frequent among PG 
women than SG or MG women (Table 1).
Factors related to antibody levels at delivery
Placental infection was associated with higher levels of 
maternal and cord IgGs against all the antigens meas-
ured (except  IESEV), as well as with maternal IgMs against 
MSP1, EBA175, AMA1 and parasite lysate (Additional 
file 1 Table S1). Peripheral infection (adjusted for placen-
tal infection) was associated with increased IgG levels 
against EBA175, parasite lysate, DBLα and the two pla-
cental isolates, as well as cord IgGs against DBLα (Addi-
tional file 1 Table S1).
Table 1 Demographic and clinical factors of mothers at delivery according to their parity
SD standard deviation, ITN insecticide-treated nets, IRS indoor residual spraying
a 41 past, 5 acute and 1 chronic infection
All (n = 207) Primigravida (n = 57) Secundigravida (n = 47) Multigravida (n = 103) p
Placental infection, n (%) 47a (23) 21 (37) 9 (19) 17 (17) 0.013
Peripheral infection, n (%) 42 (20) 14 (25) 7 (15) 21 (20) 0.473
Cord infection, n (%) 8 (4) 2 (4) 1 (2) 5 (5) 0.895
Placental density 90.5 (83.9–97.6) 81.1 (63.9–102.8) 98.55 (97.7–99.5) 92.6 (85.6–100.1) 0.166
Peripheral density
 Microscopy 3988 (894–17,778) 6663 (137–323,311) 3652 3058 (507–18,439) 0.897
 PCR 0.69 (0.25–1.88) 1.05 (0.15–7.36) 0.81 (0.02–33.5) 0.47 (0.12–2.04) 0.793
 Inflammation, n (%) 10 (5) 5 (9) 1 (2) 4 (4) 0.270
Age, mean (SD)
 15–20 years 71 (34) 44 (77) 24 (51) 3 (3) < 0.001
 21–24 years 58 (28) 12 (21) 20 (43) 26 (25)
 ≥ 25 years 78 (38) 1 (2) 3 (6) 74 (72)
Neighbourhood (< 2.5 km), n (%) 41 (20) 14 (25) 7 (30) 20 (19) 0.494
Use of ITN, n (%) 23 (11) 3 (5) 2 (4) 18 (17) 0.002
Household IRS, n (%) 98 (47) 24 (42) 21 (45) 53 (51) 0.500
Season (dry), n (%) 58 (28) 18 (32) 16 (34) 24 (23) 0.295
Low-birth weight, n (%) 28 (14) 15 (26) 6 (13) 7 (7) 0.004
Maternal anaemia, n (%) 87 (42) 23 (40) 20 (43) 44 (43) 0.792
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Maternal IgM against MSP1, EBA175, AMA1 and 
DBLα were lower in women with placental inflammation 
compared to women without inflammation (Table  2). 
 IgMAMA1 was higher in P. falciparum positive cord blood 
(10.87, SD 9.40) than in negative cords (6.82, SD 3.75, 
p = 0.023).
The use of ITNs was associated with reduced levels 
of maternal IgGs against DBLα (Additional file  1 Table 
S1), while IRS was associated with a reduction in the 
levels of maternal IgGs against lysate (Additional file  1  
Table S1). Antibodies against  IEch3 were 1.32-fold higher 
in neighbourhoods close to the river (< 2.5  km) com-
pared to those at more than < 2.5 km (95% CI [1.02; 1.69]; 
p = 0.037). There were no significant differences accord-
ing to season (all p values > 0.05).
Parity modified the association of maternal IgG and 
IgM responses as well as cord IgGs with placental infec-
tion, as indicated by the statistically significant interac-
tion terms (Fig.  1). The analysis stratified by parity and 
infection showed that the increase of antibody responses 
Table 2 Antibody responses in women with and without placental infection
GM geometric mean, SD standard deviation
a Adjusted for parity, age, neighbourhood, ITN, season and IRS
No inflammation (n = 197) Inflammation (n = 10) p Multivariatea
GM SD GM SD Ratio (95% CI) p
Maternal IgGs
 MSP1 65.41 58.42 62.84 62.76 0.891 0.88 (0.49; 1.57) 0.665
 EBA175 44.17 33.09 42.24 26.13 0.853 0.89 (0.55; 1.44) 0.636
 AMA1 61.45 37.81 63.18 30.41 0.889 0.96 (0.64; 1.42) 0.824
 DBLa 77.56 30.62 69.28 21.26 0.375 0.83 (0.65; 1.07) 0.145
 Lysate 31.68 40.32 43.07 26.07 0.450 1.16 (0.52; 2.58) 0.719
 CS2 2.16 1.62 1.83 1.07 0.492 0.93 (0.79; 1.10) 0.396
 Women1 149.75 227.78 93.63 96.67 0.336 0.68 (0.28; 1.62) 0.386
 Women2 412.18 580.46 216.39 228.31 0.156 0.56 (0.24; 1.28) 0.171
 SEV 2.72 0.88 2.39 0.90 0.228 0.97 (0.93; 1.02) 0.245
 Child1 249.09 227.92 178.53 187.45 0.266 0.67 (0.37; 1.22) 0.193
 Child2 641.87 547.08 544.20 448.88 0.550 0.82 (0.47; 1.44) 0.496
 Child3 653.83 474.55 443.80 366.64 0.103 0.67 (0.42; 1.08) 0.105
 Child4 183.91 180.67 128.46 158.73 0.267 0.64 (0.34; 1.23) 0.186
Maternal IgMs
 MSP1 75.22 45.36 40.66 32.52 0.002 0.53 (0.36; 0.80) 0.002
 EBA175 39.44 27.08 18.37 15.24 0.001 0.46 (0.29; 0.72) 0.001
 AMA1 51.87 31.25 29.61 28.32 0.006 0.58 (0.38; 0.86) 0.008
 DBLa 76.29 38.64 39.61 35.11 < 0.001 0.53 (0.38; 0.74) < 0.001
 Lysate 16.06 29.12 15.58 24.48 0.958 0.91 (0.28; 2.93) 0.87
Cord IgGs
 MSP1 54.18 51.79 41.54 45.09 0.396 0.69 (0.37; 1.28) 0.237
 EBA175 40.16 31.79 40.62 33.98 0.965 0.92 (0.55; 1.55) 0.753
 AMA1 60.89 40.77 67.26 27.17 0.643 1 (0.66; 1.53) 0.989
 DBLa 60.72 27.78 65.68 28.77 0.597 0.98 (0.73; 1.31) 0.891
 Lysate 28.55 34.11 25.50 17.50 0.768 0.77 (0.36; 1.64) 0.495
 CS2 2.30 1.73 2.12 1.39 0.726 0.98 (0.83; 1.16) 0.804
 SEV 2.61 0.81 2.35 0.74 0.304 0.98 (0.94; 1.02) 0.288
Cord IgMs
 MSP1 10.76 5.54 11.92 8.08 0.546 1.1 (0.79; 1.54) 0.575
 EBA175 4.83 3.04 6.36 6.91 0.197 1.3 (0.85; 1.99) 0.231
 AMA1 6.88 3.79 8.43 7.34 0.272 1.23 (0.85; 1.77) 0.275
 DBLa 10.67 5.45 12.57 9.02 0.335 1.18 (0.84; 1.64) 0.344
 Lysate 6.89 5.64 6.85 5.77 0.984 1.06 (0.62; 1.81) 0.827
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associated with placental infection was mainly observed 
in PG women (Fig. 1).
Factors related to pregnancy outcome and incidence 
of malaria in the children
The newborn weight increased with age and parity of 
the women, and was lower among women with a placen-
tal infection (Table  3). Haemoglobin levels were lower 
among women who had their pregnancy during the rainy 
season. Incidence of malaria during the first 1 year of life 
was higher among children born from a mother with a 
cord blood infection (Table 3).
The newborn weight decreased with increasing lev-
els of maternal  IgMEBA175 and  IgMDBLα (reductions of 
0.06  kg (95% CI [(− 0.11; − 0.01], p = 0.031 and 0.07  kg 
(95% CI [− 0.14; − 0.01], p = 0.032) with twofold increase 
in antibody levels, respectively; Additional file  1: Table 
S2). No association was found between antibody levels 
and maternal anaemia. The risk of malaria in the children 
during their 1st year of life increased with increasing lev-
els of maternal IgGs (all except  IgGch1) and cord IgGs (all 
except IgG-IESev). The multivariate analysis including all 
antibody levels showed that newborn weight increased 
with levels of  IgGlysate whereas decreased with levels of 
 IgMlysate (Fig. 2; Additional file 1: Table S3).
Discussion
This study shows that placental infection is associated 
with increased levels of maternal IgG and IgM against a 
broad range of parasite antigens and that the newborn 
weight decreases with increasing levels of IgM spe-
cific for EBA175 and DBLα. No association was found 
between IgG levels against any of the antigens tested and 
improved pregnancy outcomes when the analysis was 
performed for specific antibodies. However, higher lev-
els of IgG against a parasite lysate were associated with 
increasing birth weight when IgG and IgM were included 
in a multivariate analysis, being IgM against the parasite 
lysate associated with a reduction in the newborn weight. 
Overall, these results suggest that adjusting the analysis 
for the simultaneous effect of IgM and IgG could con-
tribute to adjust for heterogeneity in parasite exposure 
when assessing immune responses that confer protection 
against malaria infection in pregnancy, being IgM mark-
ers of parasite exposure and IgG markers of protection 
against poor pregnancy outcomes.
Results of this study confirm parasitological observa-
tions already described for malaria in pregnancy. PG 
and younger women (15–20 year) were at higher risk of 
placental infection as detected by histology [43]. This 
increased risk can be attributed to a higher susceptibil-
ity to malaria during first pregnancies due to associ-
ated immune modulation [25] and/or lack of immunity 
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Fig. 1 Association between placental infection and antibody levels 
by parity. Multivariate regression analysis adjusted by peripheral infec-
tion, age, neighbourhood, household indoor residual spraying, use of 
insecticide treated nets and season. Y axis represents the propor-
tional increase in the level of antibodies in women with a placental 
infection compared to uninfected women among primigravida (a), 
secundigravida (b) and multigravida (c). *If the p value for the interac-
tion term between parity and antibody levels was < 0.05
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against VAR2CSA expressed by placental parasites [5]. 
Differential use of preventive tools among women at 
different parities, as shown by the higher use of ITN 
among MG women compared to PG, may also contrib-
ute to reduce the risk of malaria infection in MG women. 
In accordance with this reduction of placental infection 
with increasing parity, low birth weight was more com-
mon in PG and the newborn weight was reduced in 
mothers with placental infection and younger women. 
Importantly, household IRS was also associated with 
a reduction in the prevalence of placental infection. In 
contrast to placental infection, peripheral infection was 
not found to be associated with parity, possibly because 
placental submicroscopic infections were not assessed 
in this study. Results of this study also show that inci-
dence of malaria was higher among children born from 
women living closer to the river, an association that can 
be explained by similar risk of exposure to the parasites 
in mothers and infants living in the same household [21]. 
Furthermore, this study shows that cord blood infections 
Table 3 Factors associated with newborn weight, maternal haemoglobin levels and incidence of malaria during the 
1st year of life
PG primigravida, SG secundigravida, MG multigravida, ITN insecticide-treated nets, IRS indoor residual spraying, IRR incidence rate ratio
a p < 0.05 in the multivariate analysis adjusted by age, use of IRS and ITS, season and neighbourhood
b adjusted for treatment, weight and maternal haemoglobin
Newborn weight (kg) Haemoglobin (g/L) Incidence malaria children
Mean 95% CI p Mean 95% CI p IRR 95% CI pb
Parity
 PG 2.8 2.69–2.91 < 0.001 113.1 105.4–120.7 0.878 1
 SG 2.9 2.81–2.99 113.3 107.9–119.6 1.64 0.61–4.43 0.331
 MG 3.13 3.05–3.20 111.5 107.2–115.8 1.07 0.44–2.59 0.878
Placental infection
 Negative 3.02 2.95–3.08 0.044 113 109.4–116.6 0.473 1
 Positive 2.89 2.77–2.99 110.1 102.1–118.1 0.95 0.39–2.27 0.915
Peripheral infection
 Negative 2.99 2.92–3.05 0.990 113.3 109.6–116.9 0.288 1
 Positive 2.99 2.89–3.08 108.9 101.1–116.7 1.82 0.79–4.18 0.161
Inflammation
 Negative 2.98 2.92–3.03 0.106 112.6 109.3–116.0 0.488 1
 Positive 3.19 2.92–3.46 107.0 90.26–123.7 2.96 0.72–12.02 0.130
Cord infection
 Negative 2.98 2.92–3.03 0.131 112.6 109.3–115.9 0.474 1
 Positive 3.2 2.72–3.68 106.4 88.9–123.9 5.90 1.53–22.77 0.010a
Age (years)
 15–20 2.78 2.69–2.87 < 0.001a 110.7 104.7–116.8 0.344 1
 21–24 3.03 2.95–3.12 116.2 110.0–122.3 0.79 0.31–1.98 0.608
 ≥ 25 3.14 3.05–3.23 110.9 105.7–116.0 0.88 0.38–2.05 0.769
Neighbourhood (km)
 > 2.5 3.00 2.94–3.06 0.328 111.1 114.7–107.5 0.122 1
 < 2.5 2.93 2.79–3.07 117.6 109.9–125.2 1.04 0.42–2.57 0.936
Use of ITN
 Negative 2.97 2.91–3.03 0.171 112.8 109.2–116.5 0.469 1
 Positive 3.09 2.92–3.28 109.1 102.4–115.9 1.07 0.34–3.35 0.903
Use of IRS
 Negative 2.94 2.87–3.02 0.109 113.3 108.5–118.1 0.573 1
 Positive 3.04 2.95–3.12 111.4 106.8–115.9 0.66 0.32–1.37 0.268
Season
 Rainy 2.98 2.91–3.05 0.685 110.2 106.2–114.3 0.049a 1
 Dry 3.01 2.89–3.11 117.4 111.8–123.0 0.99 0.44–2.21 0.980
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are associated with an increased risk of malaria during 
the 1st year of life, suggesting that in utero exposure can 
have a detrimental effect on the ability of newborns to 
mount an effective immune response against the parasite.
In this maternal cohort, placental infection is associ-
ated with an increase of IgG, as already shown in stud-
ies conducted in the same study area [21, 28], but also 
with increasing IgM. The magnitude of this increase was 
higher in PG than in MG, probably because parasite den-
sities are higher in first time pregnant women, leading 
to a higher boosting of antibodies. Antibody responses 
were associated with a non-significant reduction of hae-
moglobin levels in the women at delivery, and the mul-
tivariate analysis showed that IgM against the lysate 
were associated with a reduction in the newborn weight. 
Although the large number of comparisons made may 
have increased the chance of false discoveries, the fact 
that this associations with antibody responses against 
parasite lysate are maintained in the multivariate analysis 
including all the antigens suggest the genuineness of the 
observation. Moreover, antibody responses were associ-
ated with an increase in the incidence of malaria in their 
children during their 1st year of life. This association may 
be explained by a similarly high exposure to mosquito 
bites in pregnant women and their children residing in 
the same household which would translate into a boost-
ing of antibody responses in pregnant women at delivery 
and a higher malaria incidence in the children. Overall, 
these results reinforce the concept of antibodies as mark-
ers of parasite exposure and the difficulties of disentan-
gling the protective versus exposure role of antibodies 
in a situation of heterogeneous exposure. In absence of a 
continuous morbidity surveillance at antenatal care units 
to identify malaria cases and exclude from the analy-
sis those women without proven exposure during preg-
nancy (i.e., having had a malaria episode), these results 
suggest that adjusting for IgM as markers of exposure to 
the parasite can control for the heterogeneity of exposure 
[28] and contribute to identify those IgG that may have a 
role in protection. Interestingly, data of this study show 
that IgG against a parasite lysate are more associated to 
an increase in the newborn weight than IgG against the 
surface of a CSA-binding parasite line. This association 
might be explained by an antibody-mediated clearance of 
circulating parasites early at pregnancy (i.e., before these 
parasite populations switch to placental-binding, that 
0.25
0.5
1
2
4
8
16
-0.2
-0.1
0.0
0.1
0.2
-20
-10
0
10
20
0.25
0.5
1
2
4
8
M
S
P
1
E
B
A
17
5
A
M
A
1
D
B
L α
Ly
sa
te
C
S
2
IE
pl
ac
1
IE
pl
ac
2
IE
se
v
IE
ch
1
IE
ch
2
M
S
P
1
E
B
A
17
5
A
M
A
1
D
B
L
Ly
sa
te
IgGs IgMs
M
S
P
1
E
B
A
17
5
A
M
A
1
D
B
L
Ly
sa
te
C
S
2
IE
pl
ac
1
IE
pl
ac
2
IE
se
v
IE
ch
1
IE
ch
2
M
S
P
1
E
B
A
17
5
A
M
A
1
D
B
L
Ly
sa
te
IgGs IgMs
a b
dc
Pl
ac
en
ta
l i
nf
ec
tio
n
(a
nt
ib
od
y 
ra
tio
)
He
m
og
lo
bi
n 
le
ve
ls
( ∆
 g
/d
L)
Ne
w
bo
rn
 w
ei
gh
t
(
 K
g)
M
al
ar
ia
 in
ci
de
nc
e 
in
 c
hi
ld
re
n
(r
el
at
iv
e 
ri
sk
)
*
*
*
α α α
∆
Fig. 2 Association of antibody levels with maternal infection, pregnancy outcomes and incidence of malaria in children. Multivariate analysis 
including all the antibodies and adjusted for parity, age, neighbourhood, season, household indoor residual spraying and use of insecticide treated 
nets. Y axis represent the adjusted ratio of antibody levels between women with placental infection and women without infection (a), the effect of 
a twofold increase in antibody levels on the newborn weight (b), on maternal haemoglobin levels (c) and on the risk of malaria episodes in infants 
(d). Δ Expresses the increase or decrease of newborn weight or maternal haemoglobin levels with twofold increases in antibody levels. * identifies 
statistically significant p values (< 0.05)
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can contribute to prevent low birthweight. Also, immu-
nity against a broad range of P. falciparum antigens and 
not only against CS2 may have a role in controlling para-
site infections and reducing the adverse consequences of 
malaria in pregnancy.
Conclusions
Newborn weight increased with increasing IgG levels 
against a parasite lysate, whereas the opposite association 
was found with IgM, suggesting that IgG are markers of 
protection against poor pregnancy outcomes and IgM of 
parasite exposure. This study confirms the need for devel-
oping methods to control for heterogeneous exposure 
to the parasite when aiming to identify those immune 
responses that have a potential role in protection against 
infection and disease. Further studies are needed to assess 
novel approaches to disentangle exposure from protection 
in immunological studies assessing the role of antibod-
ies against the adverse consequences of malaria infection 
in situations of heterogeneous malaria exposure.
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